News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
479,088 Results
Type
Article (28715)
Company Profile (105)
Press Release (450268)
Section
Business (148322)
Career Advice (1696)
Deals (25273)
Drug Delivery (61)
Drug Development (63327)
Employer Resources (115)
FDA (12724)
Job Trends (10081)
News (251246)
Policy (21233)
Tag
Academia (1825)
Alliances (31757)
Alzheimer's disease (889)
Approvals (12687)
Artificial intelligence (92)
Bankruptcy (255)
Best Places to Work (8050)
Biosimilars (66)
Biotechnology (87)
Breast cancer (93)
Cancer (894)
Cardiovascular disease (72)
Career advice (1429)
Cell therapy (184)
Clinical research (51325)
Collaboration (277)
Compensation (154)
COVID-19 (1861)
C-suite (74)
Cystic fibrosis (71)
Data (922)
Diabetes (89)
Diagnostics (4424)
Earnings (68324)
Employer resources (104)
Events (72706)
Executive appointments (233)
FDA (13143)
Funding (262)
Gene therapy (152)
GLP-1 (439)
Government (2671)
Healthcare (13179)
Infectious disease (1924)
Inflammatory bowel disease (87)
Interviews (317)
IPO (12602)
Job creations (2305)
Job search strategy (1185)
Layoffs (322)
Legal (4588)
Lung cancer (144)
Manufacturing (111)
Medical device (9647)
Medtech (9650)
Mergers & acquisitions (12687)
Metabolic disorders (271)
Neuroscience (1111)
NextGen Class of 2024 (4354)
Non-profit (2781)
Northern California (1099)
Obesity (160)
Opinion (151)
People (39062)
Phase I (16567)
Phase II (22061)
Phase III (17222)
Pipeline (422)
Postmarket research (1844)
Preclinical (5678)
Press Release (70)
Radiopharmaceuticals (199)
Rare diseases (190)
Real estate (4012)
Regulatory (15005)
Research institute (1623)
Resumes & cover letters (277)
Southern California (940)
Startups (2584)
United States (9715)
Vaccines (420)
Weight loss (109)
Date
Last 7 days (480)
Last 30 days (2594)
Last 365 days (26741)
2024 (24561)
2023 (30460)
2022 (37923)
2021 (40375)
2020 (38088)
2019 (32417)
2018 (24599)
2017 (23612)
2016 (21902)
2015 (25999)
2014 (20103)
2013 (15955)
2012 (17169)
2011 (17788)
2010 (18371)
Location
Africa (580)
Arizona (108)
Asia (28803)
Australia (4736)
California (2374)
Canada (898)
China (197)
Colorado (96)
Connecticut (119)
Europe (61771)
Florida (300)
Georgia (74)
Illinois (226)
Indiana (125)
Maryland (375)
Massachusetts (2159)
Michigan (108)
Minnesota (235)
New Jersey (703)
New York (682)
North Carolina (511)
Northern California (1099)
Ohio (91)
Pennsylvania (538)
South America (793)
Southern California (940)
Texas (310)
Washington State (249)
479,088 Results for "credit suisse first boston corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Boston Scientific Announces Results for First Quarter 2024
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period.
April 24, 2024
·
20 min read
Genetown
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, at 8:00 a.m. ET.
April 1, 2024
·
1 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Gene therapy
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
August 14, 2024
·
2 min read
·
Tristan Manalac
Deals
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.
June 18, 2024
·
7 min read
Press Releases
Boston Scientific Announces Results for Third Quarter 2024
October 23, 2024
·
22 min read
Business
Varex Announces Closing of Revolving Credit Facility of $155 Million
Varex Imaging Corporation announced it has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.
March 27, 2024
·
3 min read
BioMidwest
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation, a specialized finance company with a focus on the global healthcare sector, providing for borrowings of up to $20 million.
January 2, 2024
·
6 min read
Business
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts and Appoints David Sutherland, CPA, as Vice President of Finance and Controller
Carrick Therapeutics Inc. today announced the relocation of its corporate headquarters from Dublin, Ireland to Boston, Massachusetts.
June 5, 2024
·
2 min read
BioCapital
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
Emergent BioSolutions Inc. announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.
April 30, 2024
·
2 min read
1 of 47,909
Next
